Known targets — ChEMBL curated mechanism
ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 known ✓ | P08172 | 20/20 | 1.00 |
| ▸ | CHRM3 known ✓ | P20309 | 20/20 | 1.00 |
| ▸ | CHRM1 known ✓ | P11229 | 19/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5011085 | 0.91 | CHRM2 (0.85) | CHRM2CHRM3CHRM1 | |
| SCHEMBL5011089 | 0.91 | CHRM2 (0.85) | CHRM2CHRM3CHRM1 | |
| Bromide SCHEMBL2816357 | 0.89 | CHRM3 (1.00) | CHRM2CHRM3CHRM1 | |
| SCHEMBL5006097 | 0.88 | CHRM2 (0.80) | CHRM2CHRM3CHRM1 | |
| SCHEMBL5006095 | 0.88 | CHRM2 (0.80) | CHRM2CHRM3CHRM1 | |
| SCHEMBL5011154 | 0.86 | CHRM2 (0.77) | CHRM2CHRM3CHRM1 | |
| SCHEMBL5011149 | 0.86 | CHRM2 (0.77) | CHRM2CHRM3CHRM1 | |
| SCHEMBL5007021 | 0.84 | CHRM2 (0.78) | CHRM2CHRM3CHRM1 | |
| SCHEMBL5007018 | 0.84 | CHRM2 (0.78) | CHRM2CHRM3CHRM1 | |
| SCHEMBL5007331 | 0.83 | CHRM2 (0.73) | CHRM2CHRM3CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7435742-B2 | Quinuclidine derivatives and pharmaceutical compositions containing the same | LABORATORIOS ALMIRALL S.A. (ES) | 2008-10-14 | — | — | US | claimed |
| US-20060094751-A1 | Quinuclidine derivatives and pharmaceutical compositions containing the same | ALMIRALL, S.A. (ES) | 2006-05-04 | — | — | US | claimed |
| EP-1515968-A2 | QUINUCLIDINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | Almirall Prodesfarma AG (CH) | 2005-03-23 | — | — | EP | claimed |
| WO-2004000840-A2 | QUINUCLIDINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | ALMIRALL PRODESFARMA AG (CH) | 2003-12-31 | — | — | WO | claimed |
| US-20100249420-A9 | Process for preparing quinuclidinium carbamate derivatives | LABORATORIOS ALMIRALL S.A. (ES) | 2010-09-30 | — | — | US | disclosed |
| US-20090198064-A1 | Process for preparing quinuclidinium carbamate derivatives | LABORATORIOS ALMIRALL S.A. (ES) | 2009-08-06 | — | — | US | disclosed |
| EP-1781651-B1 | PROCESS FOR PREPARING QUINUCLIDINIUM CARBAMATE DERIVATIVES | ALMIRALL LAB (ES) | 2009-03-11 | — | — | EP | disclosed |
| US-20090054480-A1 | NOVEL QUINUCLIDINE CARBAMATE DERIVATIVES AND MEDICINAL COMPOSITIONS CONTAINING THE SAME | LABORATORIOS ALMIRALL S.A. | 2009-02-26 | — | — | US | disclosed |
| US-20090005412-A1 | NOVEL QUINUCLIDINE DERIVATIVES AND MEDICINAL COMPOSITIONS CONTAINING THE SAME | LABORATORIOS ALMIRALL S.A. | 2009-01-01 | — | — | US | disclosed |
| US-7435742-B2 | Quinuclidine derivatives and pharmaceutical compositions containing the same | LABORATORIOS ALMIRALL S.A. (ES) | 2008-10-14 | — | — | US | disclosed |
| EP-1781651-A1 | PROCESS FOR PREPARING QUINUCLIDINIUM CARBAMATE DERIVATIVES | Laboratorios Almirall, S.A. (ES) | 2007-05-09 | — | — | EP | disclosed |
| US-20060094751-A1 | Quinuclidine derivatives and pharmaceutical compositions containing the same | ALMIRALL, S.A. (ES) | 2006-05-04 | — | — | US | disclosed |
| WO-2006010452-A1 | PROCESS FOR PREPARING QUINUCLIDINIUM CARBAMATE DERIVATIVES | LABORATORIOS ALMIRALL, S.A. (ES) | 2006-02-02 | — | — | WO | disclosed |
| EP-1515968-A2 | QUINUCLIDINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | Almirall Prodesfarma AG (CH) | 2005-03-23 | — | — | EP | disclosed |
| WO-2004000840-A2 | QUINUCLIDINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | ALMIRALL PRODESFARMA AG (CH) | 2003-12-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090005412-A1 | NOVEL QUINUCLIDINE DERIVATIVES AND MEDICINAL COMPOSITIONS CONTAINING THE SAME | CHRM3, CHRM2, CHRM1 | CHRM2 2/4885CHRM3 1/4885CHRM1 3/4885 |
| US-20060094751-A1 | Quinuclidine derivatives and pharmaceutical compositions containing the same | CHRM3, CHRM2, CHRM1 | CHRM2 2/4885CHRM3 1/4885CHRM1 3/4885 |
| US-20100249420-A9 | Process for preparing quinuclidinium carbamate derivatives | CPS1, NAAA, QPCT | CHRM2 678/4885CHRM3 549/4885CHRM1 612/4885 |
| US-20090054480-A1 | NOVEL QUINUCLIDINE CARBAMATE DERIVATIVES AND MEDICINAL COMPOSITIONS CONTAINING THE SAME | CHRM3, CHRM2, CHRM1 | CHRM2 2/4885CHRM3 1/4885CHRM1 3/4885 |
| US-20090198064-A1 | Process for preparing quinuclidinium carbamate derivatives | CPS1, NAAA, QPCT | CHRM2 678/4885CHRM3 549/4885CHRM1 612/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.